Abbott Laboratories (ABT) has a consensus analyst rating of Buy, based on 40 analysts covering the stock. Of those, 30 recommend buying, 10 recommend holding, and 0 recommend selling.
The analyst consensus price target for ABT is $137.67, representing a +36.2% upside from the current price of $101.07. Price targets range from a low of $120.00 to a high of $158.00.
